Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Heart

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 2 · 66.7%High 0 · 0%

Higher vs lower omega‐6: additional key outcomes

CHD events · adults with or without existing CVD

It is very uncertain whether higher changes CHD events: myocardial infarction (fatal or non‐fatal) or angina… compared with lower omega‐6: primary outcomes (very low certainty).

1 finding from 1 review

Omega‐6 fats for the primary and secondary prevention of cardiovascular disease 2018 · Cochrane Headline outcomes only
RR 0.88 [0.66, 1.17]
7 studies · 3997 participants
Very low

Intervention not reported

Myocardial infarction (non‐fatal) · people with cardiovascular disease or at high risk of cardiovascular disease

The intervention probably leads to lower myocardial infarction (non‐fatal) (moderate certainty).

1 finding from 1 review

Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events 2018 · Cochrane Headline outcomes only
RR 0.88 [0.81, 0.95]
6 studies · 21145 participants
Moderate

clopidogrel plus aspirin vs aspirin

Fatal or nonfatal myocardial infarction · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease

clopidogrel plus aspirin probably leads to lower fatal and non‐fatal myocardial infarction compared with aspirin alone (moderate certainty).

1 finding from 1 review

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events 2017 · Cochrane Headline outcomes only
RR 0.78 [0.69, 0.9]
6 studies · 16175 participants
Moderate